Laurence "Larry" Fink, Chairman and CEO of BlackRock.
Chris Goodney | Bloomberg | Getty Images
Company insiders are dropping stocks as stocks experience their epic boom from the coronavirus recession. Sales are a major shift from the insider buying spree during the March market lows.
Sellers include the leaders of blue chip companies like UnitedHealth and BlackRock.
The ratio of companies with insider purchases to insider sales was 0.27 in July, the lowest since at least 2000, according to Washington Service, a provider of insider trading and data analysis. The rate has dropped significantly since its 11-year high of 1.75 in March.
"I think insiders generally thought the March sell-off was too pessimistic," Raymond James analyst Tavis McCourt told CNBC. "When the market recovered, we just saw more sales and fewer purchases as prices shifted less."
The broader market has seen an epic recovery from its worst first quarter in history, caused by the Covid 19 pandemic and the economic shutdown. After falling 34% to its March low, the S&P 500 recovered in the second quarter and is now 46% below that low and positive for 2020.
During the March market, corporate insiders charged corporate stocks, signaling that US corporate leaders were confident of a recovery.
James Stanley, CEO of Morgan Stanley, sold nearly 150,000 shares of the U.S. bank worth nearly $ 8 million the day after the release of the second quarter results. Morgan Stanley's shares rose more than 85% from the bank's 52-week low in March.
This month, BlackRock's Larry Fink sold more than 40,000 shares of the company valued at approximately $ 24 million. BlackRock shares rose nearly 80% from the March low and rose 15% in 2020.
Insiders at UnitedHealth have also sold stocks, as SEC filings show. Chairman Stephen Hemsley sold nearly 230,000 shares of the healthcare giant, valued at around $ 70 million, which is about 9% of his stake. UnitedHealth's Chief Financial Officer John Rex sold approximately 69,000 shares of the company valued at more than $ 21 million. UnitedHealth stocks are only positive for the year after hitting more than 60% of their 52-week low.
James Thompson, Chairman of J.B. Hunt Transport also sold shares in the shipping company. Thompson sold 15,000 shares worth around $ 2 million last week. The J.B. Hunt stocks rose almost 75% from their lows and rose 12% over the course of the year.
Financial data remains optimistic and is mainly sold in the technology area
Amid the shift from purchase to sale, financial sector executives still charge their company stocks, according to Raymond James.
Of the companies covered by Raymond James, those in the financial sector still see nearly 16% of insiders buying stocks.
"I think more financial insiders consider their stocks to be undervalued compared to other sectors," said McCourt. "Whether you're right or not, we'll see."
The major US banks started the earnings season last week, and the US banks' top seven earnings were well above Wall Street estimates. The results were driven by a capital market-driven sales hit.
"The stronger results and the greater adequacy of the reserves should reassure investors regarding the ability of the top 7 banks to meet dividend obligations unless the Fed takes any further action," Goldman Sachs said in a note detailing all major bank profits are summarized.
While more sectors were sold than bought in most sectors, including technology, communications and materials, according to The Washington Service, the financial sector was the sector with the most similar number of purchases and sales in July. Around 6 million shares were bought in July and around 7.4 million shares were sold in the financial sector.
According to data, technology companies sold nearly 24 million shares of insiders in July compared to the 4.2 million shares bought.
Subscribe to CNBC PRO for exclusive insights and analysis, as well as live business day programs from around the world.
– With reports from Nate Rattner of CNBC.